Your browser doesn't support javascript.
loading
Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis.
Freudenhammer, Mirjam; Karampatsas, Konstantinos; Le Doare, Kirsty; Lander, Fabian; Armann, Jakob; Acero Moreno, Daniel; Boyle, Margaret; Buxmann, Horst; Campbell, Ruth; Chalker, Victoria; Cunney, Robert; Doherty, Lorraine; Davies, Eleri; Efstratiou, Androulla; Elling, Roland; Endmann, Matthias; Essers, Jochen; Hentschel, Roland; Jones, Christine E; Kallsen, Steffen; Kapatai, Georgia; Krüger, Marcus; Ladhani, Shamez; Lamagni, Theresa; Lindsay, Diane; Meehan, Mary; O'Sullivan, Catherine P; Patel, Darshana; Reynolds, Arlene J; Roll, Claudia; Schulzke, Sven; Smith, Andrew; Stein, Anja; von der Wense, Axel; Voss, Egbert; Wieg, Christian; Härtel, Christoph; Heath, Paul T; Henneke, Philipp.
Afiliación
  • Freudenhammer M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Karampatsas K; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Le Doare K; IMM-PACT Clinician Scientist Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lander F; Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Armann J; Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Acero Moreno D; Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Boyle M; Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Buxmann H; Department of Neonatology, Kinderkrankenhaus Amsterdamer Straße, Cologne, Germany.
  • Campbell R; Department of Health Northern Ireland, Belfast, United Kingdom.
  • Chalker V; Department of Pediatric and Adolescent Medicine, Division for Neonatology at the University Hospital Frankfurt, Frankfurt/Main, Germany.
  • Cunney R; Public Health Agency Northern Ireland, Belfast, United Kingdom.
  • Doherty L; Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom.
  • Davies E; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland.
  • Efstratiou A; Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.
  • Elling R; Public Health Agency Northern Ireland, Belfast, United Kingdom.
  • Endmann M; Public Health Wales, Cardiff, United Kingdom.
  • Essers J; National Infection Service, Public Health England, London, United Kingdom.
  • Hentschel R; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Jones CE; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kallsen S; Department of Pediatric and Adolescent Medicine, St. Franziskus Hospital Ahlen, Ahlen, Germany.
  • Kapatai G; Department of Pediatrics, University of Ulm, Ulm, Germany.
  • Krüger M; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Ladhani S; Faculty of Medicine and Institute for Life Sciences, University of Southampton and NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Lamagni T; Department of Paediatrics and Youth Medicine, Klinikum Friedrichshafen, Friedrichshafen, Germany.
  • Lindsay D; Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom.
  • Meehan M; Department of Neonatology, München Klinik Harlaching and Schwabing, Munich, Germany.
  • O'Sullivan CP; Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Patel D; Immunisation and Countermeasures Division, Public Health England, London, United Kingdom.
  • Reynolds AJ; National Infection Service, Public Health England, London, United Kingdom.
  • Roll C; Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.
  • Schulzke S; Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.
  • Smith A; Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Stein A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • von der Wense A; Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Voss E; Health Protection Scotland, Glasgow, United Kingdom.
  • Wieg C; Department of Neonatology, Vest Children's Hospital Datteln, University Witten-Herdecke, Witten-Herdecke, Germany.
  • Härtel C; Department of Neonatology, University Children's Hospital Basel UKBB, Basel, Switzerland.
  • Heath PT; Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.
  • Henneke P; Glasgow Dental Hospital and School, University of Glasgow, Glasgow, United Kingdom.
Front Immunol ; 12: 617925, 2021.
Article en En | MEDLINE | ID: mdl-34149682
Group B Streptococcus (GBS) is a common intestinal colonizer during the neonatal period, but also may cause late-onset sepsis or meningitis in up to 0.5% of otherwise healthy colonized infants after day 3 of life. Transmission routes and risk factors of this late-onset form of invasive GBS disease (iGBS) are not fully understood. Cases of iGBS with recurrence (n=25) and those occurring in parallel in twins/triplets (n=32) from the UK and Ireland (national surveillance study 2014/15) and from Germany and Switzerland (retrospective case collection) were analyzed to unravel shared (in affected multiples) or fixed (in recurrent disease) risk factors for GBS disease. The risk of iGBS among infants from multiple births was high (17%), if one infant had already developed GBS disease. The interval of onset of iGBS between siblings was 4.5 days and in recurrent cases 12.5 days. Disturbances of the individual microbiome, including persistence of infectious foci are suggested e.g. by high usage of perinatal antibiotics in mothers of affected multiples, and by the association of an increased risk of recurrence with a short term of antibiotics [aOR 4.2 (1.3-14.2), P=0.02]. Identical GBS serotypes in both recurrent infections and concurrently infected multiples might indicate a failed microbiome integration of GBS strains that are generally regarded as commensals in healthy infants. The dynamics of recurrent GBS infections or concurrent infections in multiples suggest individual patterns of exposure and fluctuations in host immunity, causing failure of natural niche occupation.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones Estreptocócicas / Streptococcus / Sepsis / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Disbiosis / Antibacterianos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Newborn / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones Estreptocócicas / Streptococcus / Sepsis / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Disbiosis / Antibacterianos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Newborn / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Alemania